iAnthus Capital Holdings (FRA:2IA) 9-Day RSI: 47.06 (As of Jul. 07, 2026)


What is iAnthus Capital Holdings 9-Day RSI?

iAnthus Capital Holdings FRA:2IA 9-Day RSI is 47.06 as of Jul. 07, 2026. The stock has 4 warning signs investors should review. Among 1,047 Drug Manufacturers companies, iAnthus Capital Holdings ranks better than 69.82% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-07-07), iAnthus Capital Holdings's 9-Day RSI is 47.06.

The industry rank for iAnthus Capital Holdings's 9-Day RSI or its related term are showing as below:

FRA:2IA's 9-Day RSI is ranked better than
69.82% of 1047 companies
in the Drug Manufacturers industry
Industry Median: 54.44 vs FRA:2IA: 47.06

iAnthus Capital Holdings  (FRA:2IA) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

iAnthus Capital Holdings 9-Day RSI Related Terms

FRA:2IA vs ZTS, UTHR: 9-Day RSI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, iAnthus Capital Holdings's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iAnthus Capital Holdings 9-Day RSI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, iAnthus Capital Holdings's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where iAnthus Capital Holdings's 9-Day RSI falls into.


iAnthus Capital Holdings  (FRA:2IA) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100–[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 9-Day RSI →
What does a 9-Day RSI of 47.06 mean?
iAnthus Capital Holdings (FRA:2IA) has a 9-Day RSI of 47.06 as of Jul. 07, 2026. According to the industry distribution chart, iAnthus Capital Holdings ranks #316 out of 1047 companies in the Drug Manufacturers industry, placing it in the top 30.2%.
Is iAnthus Capital Holdings' 9-Day RSI too high?
iAnthus Capital Holdings' current 9-Day RSI is 47.06. The Drug Manufacturers industry median 9-Day RSI is 54.44. iAnthus Capital Holdings' value of 47.06 is 13.6% below this industry median. Based on the distribution chart, iAnthus Capital Holdings ranks #316 out of 1047 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does iAnthus Capital Holdings' 9-Day RSI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, iAnthus Capital Holdings ranks #316 out of 1047 companies for 9-Day RSI. This puts iAnthus Capital Holdings in the upper half of its industry. The industry median 9-Day RSI is 54.44. iAnthus Capital Holdings' value of 47.06 is 13.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Drug Manufacturers company?
The median 9-Day RSI among Drug Manufacturers companies is 54.44, based on 1,047 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iAnthus Capital Holdings's current 9-Day RSI of 47.06 is 13.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median 9-Day RSI is 54.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iAnthus Capital Holdings's current 9-Day RSI is 47.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iAnthus Capital Holdings stock overvalued right now?
iAnthus Capital Holdings (FRA:2IA) has a current 9-Day RSI of 47.06. The current 9-Day RSI is 47.06 and 13.6% below the Drug Manufacturers industry median of 54.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For iAnthus Capital Holdings (FRA:2IA), the current 9-Day RSI is 47.06 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

iAnthus Capital Holdings Business Description

Other Exchanges ITHUF:USAIAN:Canada
Address 214 King Street West, Suite 314, Toronto, ON, CAN, M5H 3S6
iAnthus Capital Holdings Inc is a vertically-integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities and a developer, producer, and distributor of branded cannabis products in the United States. Its Cannabis product offerings include flower and trim, products containing cannabis flower and trim (such as packaged flower and pre-rolls), cannabis infused products (such as topical creams and edibles), and products containing cannabis extracts (such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures). The company's reportable operating segments are the Eastern Region, which generates the maximum revenue, and the Western Region.